Key result
Aspirin thromboprophylaxis following total hip or knee arthroplasty demonstrated comparable VTE prevention to other anticoagulants with a lower incidence of postoperative bleeding.
Why the study?
Venous thromboembolism and pulmonary embolism pose substantial risks after large joint replacement, prompting evaluation of the effectiveness of aspirin for thromboprophylaxis following TKA or THA.
Does aspirin 100 mg daily safely and effectively prevent venous thromboembolism compared to other anticoagulants in patients undergoing total hip or knee arthroplasty?
Cohort (n=1,000)
No
Does aspirin 100 mg daily safely and effectively prevent venous thromboembolism compared to other anticoagulants in patients undergoing total hip or knee arthroplasty?
Aspirin 100 mg daily is a safe and effective alternative to other anticoagulants for VTE prophylaxis following total hip or knee arthroplasty, demonstrating comparable efficacy with a lower incidence of postoperative bleeding.
Answers are grounded in this paper and cite their sources.
Aspirin was associated with similar VTE/PE rates versus other anticoagulants post-THA/TKA; leaves open its role as routine prophylaxis pending RCTs.
PURPOSE OF THE STUDY: Given the risk of venous thromboembolism (DVT) and pulmonary embolism (PE) after large joint replacement, the role of thromboprophylaxis is crucial. This retrospective study aims to evaluate the effectiveness of aspirin as thromboprophylaxis in patients undergoing TKA or THA. MATERIAL AND METHODS: In this retrospective review of a database of patients who underwent total hip and total knee replacements between 2021 and 2023, we divided patients into two groups: those with no anticoagulation therapy before surgery and those on chronic anticoagulant use prior to surgery. The primary endpoint was the number of patients with complications after aspirin use in the postoperative period. We collected patient demographic information, history of anticoagulant use, postoperative anticoagulant usage, comorbidities, type of surgery, reactions to anticoagulants, complications related to thromboembolism, length of hospital stay, and hospital readmissions. RESULTS: For patients who underwent elective THA or TKA, no significant difference in overall VTE or PE rates was detected when comparing aspirin with other anticoagulants. No mortality events were reported. However, there were differences in bleeding event rates between the aspirin group and other anticoagulant groups. CONCLUSIONS: Proper patient selection and early postoperative mobilization support the use of aspirin as a thromboprophylaxis therapy. The results of this study confirm that aspirin is a safe alternative to other anticoagulants in the postoperative management of THA and TKA.
No takes yet. Share an insight, caveat, or question.
Benkovich et al. (2025) conducted a cohort in Total hip or knee arthroplasty (n=1,000). Aspirin vs. Other anticoagulants (e.g., rivaroxaban, apixaban, dabigatran, enoxaparin) was evaluated on Postoperative complications (VTE, PE, and bleeding). Aspirin thromboprophylaxis following total hip or knee arthroplasty demonstrated comparable VTE prevention to other anticoagulants with a lower incidence of postoperative bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: